AptaBio Therapeutics Inc.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

www.aptabio.com

Country

South Korea

Exchange

KOSDAQ

Founded 2009

AptaBio Therapeutics Inc., a biopharmaceutical company develops platform based drugs for intractable diseases. Its platforms include Oxidative stress modulation platform for developing therapeutic agents for diabetes complications, vascular diseases, neurodegenerative diseases, and intractable cancers by controlling oxidative stress.

Its portfolio also includes Cancer-associated fibroblast control platform for developing new anticancer drugs for intractable cancer, and Aptamer-drug conjugate platform for developing intractable anticancer drugs with high unmet medical needs.

The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX reagents for transfecting DNA or RNA into eukaryotic cells. Founded in 2009, the company is based in Yongin-si, South Korea.

Key Stats

52-Week Range

₩3870.00₩10890.00

Beta0.82

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.